These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
898 related articles for article (PubMed ID: 23610145)
1. Dual regulation of osteopontin production by TLR stimulation in dendritic cells. Salvi V; Scutera S; Rossi S; Zucca M; Alessandria M; Greco D; Bosisio D; Sozzani S; Musso T J Leukoc Biol; 2013 Jul; 94(1):147-58. PubMed ID: 23610145 [TBL] [Abstract][Full Text] [Related]
2. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists. Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456 [TBL] [Abstract][Full Text] [Related]
3. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells. Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289 [TBL] [Abstract][Full Text] [Related]
4. PKC-alpha controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells. Langlet C; Springael C; Johnson J; Thomas S; Flamand V; Leitges M; Goldman M; Aksoy E; Willems F Eur J Immunol; 2010 Feb; 40(2):505-15. PubMed ID: 19950169 [TBL] [Abstract][Full Text] [Related]
5. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I. Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149 [TBL] [Abstract][Full Text] [Related]
6. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands. de Vos AF; Pater JM; van den Pangaart PS; de Kruif MD; van 't Veer C; van der Poll T J Immunol; 2009 Jul; 183(1):533-42. PubMed ID: 19542464 [TBL] [Abstract][Full Text] [Related]
7. Expression of TRAF6 and pro-inflammatory cytokines through activation of TLR2, TLR4, NOD1, and NOD2 in human periodontal ligament fibroblasts. Tang L; Zhou XD; Wang Q; Zhang L; Wang Y; Li XY; Huang DM Arch Oral Biol; 2011 Oct; 56(10):1064-72. PubMed ID: 21457942 [TBL] [Abstract][Full Text] [Related]
8. TLR4-mediated pro-inflammatory dendritic cell differentiation in humans requires the combined action of MyD88 and TRIF. Kolanowski ST; Dieker MC; Lissenberg-Thunnissen SN; van Schijndel GM; van Ham SM; ten Brinke A Innate Immun; 2014 May; 20(4):423-30. PubMed ID: 23941760 [TBL] [Abstract][Full Text] [Related]
9. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling. Wang S; Schmaderer C; Kiss E; Schmidt C; Bonrouhi M; Porubsky S; Gretz N; Schaefer L; Kirschning CJ; Popovic ZV; Gröne HJ Dis Model Mech; 2010; 3(1-2):92-103. PubMed ID: 20038715 [TBL] [Abstract][Full Text] [Related]
10. TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like. Siednienko J; Halle A; Nagpal K; Golenbock DT; Miggin SM Eur J Immunol; 2010 Nov; 40(11):3150-60. PubMed ID: 20957750 [TBL] [Abstract][Full Text] [Related]
11. Human Binge Alcohol Intake Inhibits TLR4-MyD88 and TLR4-TRIF Responses but Not the TLR3-TRIF Pathway: HspA1A and PP1 Play Selective Regulatory Roles. Muralidharan S; Lim A; Catalano D; Mandrekar P J Immunol; 2018 Apr; 200(7):2291-2303. PubMed ID: 29445009 [TBL] [Abstract][Full Text] [Related]
12. TLR2 promotes Th2/Th17 responses via TLR4 and TLR7/8 by abrogating the type I IFN amplification loop. Wenink MH; Santegoets KC; Broen JC; van Bon L; Abdollahi-Roodsaz S; Popa C; Huijbens R; Remijn T; Lubberts E; van Riel PL; van den Berg WB; Radstake TR J Immunol; 2009 Dec; 183(11):6960-70. PubMed ID: 19915052 [TBL] [Abstract][Full Text] [Related]
13. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling. Piao W; Song C; Chen H; Diaz MA; Wahl LM; Fitzgerald KA; Li L; Medvedev AE J Leukoc Biol; 2009 Oct; 86(4):863-75. PubMed ID: 19656901 [TBL] [Abstract][Full Text] [Related]
14. Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/Trif. Lichtnekert J; Vielhauer V; Zecher D; Kulkarni OP; Clauss S; Segerer S; Hornung V; Mayadas TN; Beutler B; Akira S; Anders HJ Am J Physiol Renal Physiol; 2009 Apr; 296(4):F867-74. PubMed ID: 19158348 [TBL] [Abstract][Full Text] [Related]
15. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817 [TBL] [Abstract][Full Text] [Related]
16. Identification of a TLR4- and TRIF-dependent activation program of dendritic cells. Weighardt H; Jusek G; Mages J; Lang R; Hoebe K; Beutler B; Holzmann B Eur J Immunol; 2004 Feb; 34(2):558-64. PubMed ID: 14768061 [TBL] [Abstract][Full Text] [Related]
17. The combination of maltose-binding protein and BCG-induced Th1 activation is involved in TLR2/9-mediated upregulation of MyD88-TRAF6 and TLR4-mediated downregulation of TRIF-TRAF3. Liu G; Zhai X; Zhou H; Yang X; Zhang N; Tai G; Ni W Cell Immunol; 2018 Mar; 325():56-63. PubMed ID: 29452695 [TBL] [Abstract][Full Text] [Related]
18. Bacterial lipopolysaccharide induces increased expression of toll-like receptor (TLR) 4 and downstream TLR signaling molecules in bovine mammary epithelial cells. Ibeagha-Awemu EM; Lee JW; Ibeagha AE; Bannerman DD; Paape MJ; Zhao X Vet Res; 2008; 39(2):11. PubMed ID: 18096120 [TBL] [Abstract][Full Text] [Related]
19. Escherichia coli maltose-binding protein (MBP) activates mouse Th1 through TLR2-mediated MyD88-dependent pathway and TLR4-mediated TRIF-dependent pathway. Liu G; Zhang Y; Zhang N; Ni W; Jie J; Jiang L; Tai G Int Immunopharmacol; 2017 Sep; 50():338-344. PubMed ID: 28750349 [TBL] [Abstract][Full Text] [Related]